Metformin 500mg + Glimepiride 1mg tablet

107.00

Brand Name : Ride M1

Packaging

Blister | 10×15

Composition

Metformin 500mg + Glimepiride 1mg

Ride M1 is a Metformin 500mg + Glimepiride 1mg tablet used to help control blood sugar levels in adults with Type 2 diabetes as part of a comprehensive management plan.

WHO-GMP Manufactured
Available for PCD Franchise

Ride M1 is a Metformin 500mg + Glimepiride 1mg tablet used for the management of Type 2 diabetes. It combines Metformin, which helps reduce glucose production in the liver and improves insulin sensitivity, with Glimepiride, which stimulates the pancreas to release insulin.

This dual-action approach helps control blood sugar levels more effectively. Ride M1 is typically prescribed when diet, exercise, and single-drug therapy are not sufficient. It supports better glycemic control when used as directed by a healthcare professional and as part of a balanced lifestyle including proper diet and regular physical activity.

Composition

IngredientStrengthPurpose
Metformin500 mgHelps lower blood glucose production
Glimepiride1 mgStimulates insulin release for better sugar control

How Does Metformin 500mg + Glimepiride 1mg Tablet Work?

  • Step 1: After oral intake, the tablet is absorbed into the bloodstream through the digestive system.
  • Step 2: It starts acting on different mechanisms involved in blood sugar regulation.
  • Step 3: Metformin reduces glucose production in the liver and improves the body’s response to insulin.
  • Step 4: Glimepiride stimulates the pancreas to release more insulin, helping lower blood sugar levels.
  • Step 5: This combined action helps control blood sugar levels more effectively when used along with proper diet and exercise.

Key Benefits of Metformin 500mg + Glimepiride 1mg Tablet

  • Dual-action blood sugar control: Combines two mechanisms to help manage blood glucose levels more effectively.
  • Improves insulin response: Metformin helps the body use insulin more efficiently.
  • Supports insulin release: Glimepiride helps stimulate insulin secretion from the pancreas.
  • Helps manage Type 2 diabetes: Commonly prescribed when diet and exercise alone are not sufficient.
  • Supports overall glycemic control: Helps maintain stable blood sugar levels when used as directed.
  • Complements lifestyle changes: Works best along with proper diet and regular physical activity.

Metformin 500mg + Glimepiride 1mg Tablet Uses & Indications

  • Type 2 diabetes management: Commonly used to help control blood sugar levels in adults with Type 2 diabetes.
  • When single therapy is not enough: Prescribed when diet, exercise, or single-drug treatment does not provide adequate control.
  • Improving glycemic control: Helps maintain stable blood glucose levels throughout the day.
  • Insulin resistance support: Metformin helps improve the body’s response to insulin.
  • Adjunct to lifestyle management: Used along with proper diet, weight control, and physical activity for better diabetes management.

Metformin 500mg + Glimepiride 1mg tablet should be used under medical supervision and as part of a comprehensive diabetes management plan.

Metformin 500mg + Glimepiride 1mg Tablet Dosage & Administration

AspectDetails
Prescription GuidanceThis medicine should be taken only as prescribed by a qualified healthcare professional.
Recommended DosageThe dose is decided by the doctor based on blood sugar levels and patient response.
Method of IntakeTake the tablet orally with water. Swallow it whole without crushing or chewing.
When to TakeIt is usually taken with meals to reduce stomach discomfort and help control blood sugar levels.
Duration of UseDiabetes management is long-term; follow the doctor’s advice for continuous use.
Missed DoseIf a dose is missed, take it with the next meal when remembered. Do not take a double dose.

Warnings & Precautions

  • Use under medical supervision: This medicine should be taken only when prescribed by a qualified healthcare professional.
  • Risk of low blood sugar (hypoglycemia): Glimepiride may lower blood sugar levels. Monitor symptoms like dizziness, sweating, or weakness.
  • Kidney and liver conditions: Patients with kidney or liver disorders should use this medicine with caution and under medical guidance.
  • Take with meals: It is advisable to take the medicine with food to reduce stomach discomfort and help maintain stable blood sugar levels.
  • Avoid alcohol consumption: Alcohol may increase the risk of low blood sugar and other side effects.
  • Regular monitoring required: Blood glucose levels should be checked regularly as advised by the doctor.
  • Pregnancy and breastfeeding: Use only if advised by a healthcare professional after proper evaluation.

FAQs

Q1: What is Metformin 500mg + Glimepiride 1mg tablet used for?

Ans: It is used to help control blood sugar levels in adults with Type 2 diabetes as part of a proper treatment plan.

Q2: How does Metformin + Glimepiride tablet work?

Ans: It works by reducing glucose production in the liver and increasing insulin release to help lower blood sugar levels.

Q3: Can this medicine cure diabetes?

Ans: No, it helps manage blood sugar levels but does not cure diabetes. Lifestyle changes are also important.

Q4: When should I take this medicine?

Ans: It is usually taken with meals as advised by a healthcare professional.

Q5: What are the signs of low blood sugar?

Ans: Symptoms may include sweating, dizziness, weakness, and confusion. Seek medical advice if these occur.

Q6: Is this medicine safe for long-term use?

Ans: Yes, it is often used for long-term management of diabetes under medical supervision.

Q7: Can I take this medicine without food?

Ans: It is generally recommended to take it with food to reduce stomach discomfort and maintain stable blood sugar levels.

Q8: What are the common side effects of this medicine?

Ans: Some individuals may experience mild effects like stomach upset, nausea, or low blood sugar.

Reviews

There are no reviews yet.

Be the first to review “Metformin 500mg + Glimepiride 1mg tablet”

Your email address will not be published. Required fields are marked *